We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVB.WS
4976
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$237 ﹤0.01%
1,638
-280
-15% -$37
CBIO
4977
Crescent Biopharma
CBIO
$555M
$230 ﹤0.01%
+1
New +$147
AGQ icon
4978
ProShares Ultra Silver
AGQ
$1.2B
$224 ﹤0.01%
7
NRP icon
4979
Natural Resource Partners
NRP
$1.31B
$217 ﹤0.01%
+4
New +$175
TEN
4980
Tsakos Energy Navigation Ltd
TEN
$1.2B
$204 ﹤0.01%
12
-5,640
-100% -$98.7K
PXMD
4981
DELISTED
PaxMedica, Inc. Common Stock
PXMD
$204 ﹤0.01%
+6
New +$214
INFI
4982
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$199 ﹤0.01%
359
-13,293
-97% -$11.3K
UPRO icon
4983
ProShares UltraPro S&P 500
UPRO
$5.13B
$197 ﹤0.01%
6
GBR icon
4984
New Concept Energy
GBR
$3.52M
$194 ﹤0.01%
178
AILEW
4985
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$191 ﹤0.01%
38,200
CORN icon
4986
Teucrium Corn Fund
CORN
$177M
$189 ﹤0.01%
7
WIT icon
4987
Wipro
WIT
$19.3B
$182 ﹤0.01%
78
+2
+3% +$5
JDST icon
4988
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$29.5M
0
NPCE icon
4989
Neuropace
NPCE
$469M
$176 ﹤0.01%
118
-3,100
-96% -$6.89K
DMTK
4990
DELISTED
DermTech, Inc. Common Stock
DMTK
$172 ﹤0.01%
97
-600
-86% -$1.6K
PDOT.WS
4991
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$169 ﹤0.01%
3,615
DCBO
4992
Docebo
DCBO
$528M
$166 ﹤0.01%
5
-3
-38% -$90
LANV.WS
4993
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$150 ﹤0.01%
+500
New +$131
CX icon
4994
Cemex
CX
$17.2B
$146 ﹤0.01%
36
SRS icon
4995
ProShares UltraShort Real Estate
SRS
$15.2M
$146 ﹤0.01%
2
CLNN icon
4996
Clene
CLNN
$64.4M
$140 ﹤0.01%
7
-26
-79% -$603
OHAA
4997
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$140 ﹤0.01%
14
ANGI icon
4998
Angi Inc
ANGI
$229M
$127 ﹤0.01%
5
TWNI.WS
4999
DELISTED
Tailwind International Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TWNI.WS
$127 ﹤0.01%
31,015
AAU
5000
DELISTED
Almaden Minerals Ltd
AAU
$122 ﹤0.01%
500

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.